No. | Title | Date | View |
---|---|---|---|
48 | 2022-11-28 | 346 | |
47 |
OliX Announces Positive Preclinical Data in NASH Non-human Primate Models
|
2022-11-10 | 319 |
46 |
OliX Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for AMD
|
2022-08-08 | 932 |
45 | 2022-07-05 | 947 | |
44 | 2022-07-05 | 787 | |
43 | 2022-06-13 | 842 | |
42 | 2022-06-07 | 916 | |
41 | 2022-05-27 | 1561 | |
40 | 2022-05-27 | 801 | |
39 | 2022-04-12 | 1101 | |
38 |
OliX Pharmaceuticals to Participate in BIO-Europe Spring®
|
2022-03-24 | 1121 |
37 | 2022-03-22 | 1294 | |
36 |
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference
|
2022-03-22 | 988 |
35 | 2022-03-22 | 856 | |
34 |
OliX Pharmaceuticals Subsidiary mCureX Strengthens Scientific Advisory Board
|
2022-03-22 | 805 |
33 | 2022-03-22 | 794 | |
32 |
OliX Pharmaceuticals Enters Agreement with Pharmaron
|
2022-03-22 | 879 |
31 |
Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing and Collaboration Agreement
|
2021-10-19 | 2860 |
30 | 2021-08-17 | 3593 | |
29 | 2021-08-05 | 3290 |
- Home
- PR